
mPharma
Medicine supply, pharmacy software and a pharmacy network for patients in West Africa.
Accra, Ghanampharma.comVerified 17 Oct 2026Updated 17 Oct 2026
- Total raised
- $87m
- 7 of 8 rounds with a disclosed amount
- Valuation
- $113.5m
- Reported 1 Oct 2026
- Latest round
- Growth equity
- 3 Nov 2025
- Stage
- Growth
- Latest reported
- Team
- 201–500
- People, estimated
- Founded
- 2013
- 13 years ago
- Headquarters
- Accra
- Ghana
Overview
mPharma is an Accra health company founded in 2013 by Gregory Rockson, Daniel Shoukimas and James Finucane. It buys and finances medicine stock for community pharmacies, runs Bloom pharmacy software, franchises independent pharmacies under QualityRx and runs mutti, a free patient membership. Its investors include Social Capital, Novastar Ventures, British International Investment, Lux Capital and the Sanofi Global Health Unit Impact Fund. It bought Kenya's Haltons in 2019, 55% of Uganda's Vine Pharmacy in 2021 and a majority of Nigeria's HealthPlus in 2022, and cut about 150 jobs in September 2023. Kwesi Arhin became chief executive on 1 September 2025 and Rockson became chair. In November 2025 GIP Ghana invested to take QualityRx into Togo and Benin.
- Sectors
- Healthtech
- Business model
- B2B, B2C, Franchise
- Customers
- SME, Consumer
- Markets
- Ghana, Benin, Togo, Nigeria
Products and services
- Vendor-managed inventory
mPharma buys, stocks and finances medicines for partner pharmacies, which pay only for what they dispense. It started this model with pharmacies in Zambia.
- Bloom
Pharmacy and health management software that runs mPharma's partner pharmacies, including primary care, telemedicine and chronic disease support.
- QualityRx
Franchise programme that refits independent pharmacies and runs them on Bloom, with better drug prices, inventory financing and patients sent through mutti. Being taken to Togo and Benin from 2025.
- mutti
Free health membership for patients at mutti pharmacies: discounts, interest-free payment plans and health screenings. About 400,000 members by the end of 2024.
- mutti pharmacies
Community pharmacies that also offer consultations, diagnostic tests and telehealth. mPharma had 200 when it raised its Series D in January 2022.
- mutti Doctor
Telemedicine consultations offered through mutti pharmacies.
- mutti+
Subscription plan launched in Nigeria in April 2023: free primary care consultations, free lab tests and 150 medicines for under ₦1,000 a month at mutti pharmacies.
- mymutti app and shop
Android app and mymutti.com shop for mutti members: wallet and loyalty balances, Heal Now Pay Later, pharmacy finder and ordering in Ghana and Nigeria.
- Diabetes Test & Treat
Diabetes care programme at mPharma pharmacies. mPharma says 80% of enrolled patients reached good blood sugar control within six months.
Funding rounds
Valuation. Valued at $114m as reported in Oct 2026, below the $1bn line. Source
| Date | Round | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| 3 Nov 2025 | Growth equity | Undisclosed | — | Growth Investment Partners Ghana (lead) | Source |
| 30 Jan 2024 | Growth equity | $13.67m | — | Source | |
| 5 Jan 2022 | Debt | $5m | — | Citibank (lead) | Source |
| 5 Jan 2022 | Series D or later | $30m | — | Northstar, TO Ventures | Source |
| 26 May 2020 | Series C | $17m | — | Novastar Ventures (lead), Daniel Vasella, Dompé Holdings | Source |
| 10 Jan 2019 | Series B | $9.73m | — | Shravin Bharti Mittal | Source |
| 23 Nov 2017 | Series A | $6.6m | — | Shravin Bharti Mittal (lead) | Source |
| 28 Jan 2016 | Seed | $5m | — | Social Capital (lead) | Source |
Only published rounds count. “Undisclosed” means the amount was not made public; it is never estimated.
People
- Philip Sowah
Board · Director
- Ashley Carroll
Board · Board member (not in SEC filings)
- Gregory Rockson
Founder
- Daniel Shoukimas
Founder
- James Finucane
Founder
Latest
GIP Ghana invested in mPharma Ghana to expand its QualityRx franchise into Togo and Benin · 3 Nov 2025
Milestones
- Kwesi Arhin became chief executive
Arhin, the chief operating officer, replaced co-founder Gregory Rockson, who became chair after 12 years as chief executive.
Source - Reached $1.5M annual revenue run rate in Francophone Africa
Reached in seven months, with teams being built in Benin, Togo and Côte d'Ivoire.
Source - Laid off about 150 staff
About 40 of the jobs were in Nigeria. Rockson cited the naira's devaluation.
Source - Launched mutti+ in Nigeria
A primary care subscription for under ₦1,000 a month, aimed at 200,000 people in its first year.
Source - Took a majority stake in HealthPlus, Nigeria
Bought from Alta Semper Capital. mPharma's Nigerian network grew from 224 to more than 320 health facilities in 12 states.
Source - Bought 55% of Uganda's Vine Pharmacy
Bought the stake held by the collapsed Abraaj Group. Vine had 20 branches in Uganda.
Source - Entered Ethiopia, its eighth market
Franchise deal through Haltons with Belayab Pharmaceuticals to open two pharmacies in Addis Ababa.
Source - Supplied COVID-19 testing to labs
Procured and distributed 700,000 testing kits and 120 PCR machines to labs in several African countries.
Source - Helena Foulkes joined the board
The former president of CVS Pharmacy joined as mPharma raised $17M.
Source - Won a Skoll Award for Social Entrepreneurship
Awarded at the Skoll World Forum in Oxford for its vendor-managed inventory model in Zambia.
Source - Agreed to buy Haltons, Kenya's second-largest pharmacy chain
Bought from Fanisi Capital for under $5M, with 20 stores in Nairobi and Mombasa. mPharma's first East African market.
Source - Won the World Health Summit Startup Track
Picked first of 10 finalists, from more than 70 applicants, in Berlin.
Source - Founded
Gregory Rockson, Daniel Shoukimas and James Finucane started mPharma in Ghana.
Source
Hiring
No open roles are listed for mPharma right now. Check its own site at mpharma.com. A role appears here once it is on the company’s own careers page and an editor has checked it.
Sources
- Main source for this record
- Growth equity, 3 Nov 2025
- Growth equity, 30 Jan 2024
- Debt, 5 Jan 2022
- Series D or later, 5 Jan 2022
- Series C, 26 May 2020
- Series B, 10 Jan 2019
- Series A, 23 Nov 2017
- Seed, 28 Jan 2016
- Kwesi Arhin became chief executive, 1 Sep 2025
- Reached $1.5M annual revenue run rate in Francophone Africa, October 2024
- Laid off about 150 staff, 4 Sep 2023
- Launched mutti+ in Nigeria, 7 Apr 2023
- Took a majority stake in HealthPlus, Nigeria, 15 Sep 2022
- Bought 55% of Uganda's Vine Pharmacy, 26 Oct 2021
- Entered Ethiopia, its eighth market, 10 Mar 2021
- Supplied COVID-19 testing to labs, June 2020
- Helena Foulkes joined the board, 26 May 2020
- Won a Skoll Award for Social Entrepreneurship, 10 Apr 2019
- Agreed to buy Haltons, Kenya's second-largest pharmacy chain, 29 Mar 2019
- Won the World Health Summit Startup Track, 11 Oct 2015
- Founded, 2013